AAV_Efs_hSpCas9_NLS_FLAG-SV40 Citations (2)
Originally described in: Homology-mediated end joining-based targeted integration using CRISPR/Cas9.Yao X, Wang X, Hu X, Liu Z, Liu J, Zhou H, Shen X, Wei Y, Huang Z, Ying W, Wang Y, Nie YH, Zhang CC, Li S, Cheng L, Wang Q, Wu Y, Huang P, Sun Q, Shi L, Yang H Cell Res. 2017 May 19. doi: 10.1038/cr.2017.76. PubMed Journal
Articles Citing AAV_Efs_hSpCas9_NLS_FLAG-SV40
Articles |
---|
CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy. Yao X, Wang X, Liu J, Shi L, Huang P, Yang H. J Vis Exp. 2018 Mar 12;(133). doi: 10.3791/56844. PubMed |
Tild-CRISPR Allows for Efficient and Precise Gene Knockin in Mouse and Human Cells. Yao X, Zhang M, Wang X, Ying W, Hu X, Dai P, Meng F, Shi L, Sun Y, Yao N, Zhong W, Li Y, Wu K, Li W, Chen ZJ, Yang H. Dev Cell. 2018 May 21;45(4):526-536.e5. doi: 10.1016/j.devcel.2018.04.021. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.